ANRIL

ncRNA information

ncRNA name

ANRIL

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

No

Biomarker application

Upstream regulatory factors

MK

Downstream target

Not available

Cancer information

Cancer name

Oral Squamous Cell Carcinoma

Cancer site

Lip, Oral Cavity

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

CAFs in the TME contribute to the high level of MK in tumours and that CAF-derived MK can promote cisplatin resistance via the elevated expression of lncRNA ANRIL.

Tissue resource

paired oral squamous cell cancer tissues and adjacent non-tumour tissues

normal human keratinocyte cell lines HaCaT

human oral squamous cancer cell lines OSCC3

human oral squamous cancer cell lines SCC4

human oral squamous cancer cell lines HSC3

human oral squamous cancer cell linesCAL27

Experiment

qRT-PCR,Western blot


Institute

Nanjing Stomatology Hospital Affiliated to Nanjing University

Country

China

Continent

Asia